Fakultna Nemocnica Trnava

At Fakultna Nemocnica Trnava, the Dermatovenerologicka klinika is actively involved in studies across skin and connective tissue diseases and immune system diseases, with a strong focus on chronic inflammatory skin conditions. Research is centered on conditions such as hidradenitis suppurativa, atopic dermatitis, bullous pemphigoid, urticaria, and vitiligo, aiming to evaluate new treatment options and improve long-term disease control.

• Testing new therapies for chronic inflammatory skin disorders
• Evaluating safety and effectiveness in difficult-to-treat dermatologic diseases
• Studying treatment approaches for pigment and blistering skin conditions

This research supports better symptom relief, disease management, and treatment choices for patients with persistent skin and allergic conditions.

Clinical trials at the site also cover nervous system diseases, especially immune-related and relapsing neurological disorders. The main conditions studied include multiple sclerosis, chronic inflammatory demyelinating polyneuropathy, refractory status epilepticus, and lower limb spasticity. These studies are designed to assess new treatments, support relapse prevention, and improve neurological function and quality of life.

• Exploring therapies for relapsing and progressive forms of multiple sclerosis
• Assessing treatment options for inflammatory neuropathies
• Evaluating medicines for severe seizure-related and movement-related disorders

The work reflects a strong interest in advanced neuroimmunology and in improving care for patients with complex neurological disease.

The clinical trial portfolio includes important studies in cardiovascular diseases and nutritional and metabolic diseases, with overlap in kidney disease and blood pressure management. Research targets atherosclerotic cardiovascular disease, acute ischemic stroke, chronic kidney disease, and related high-risk conditions. The main purpose is to test whether new therapies can reduce major events, slow disease progression, and improve long-term outcomes.

• Preventing stroke and other serious vascular complications
• Slowing progression of chronic kidney disease
• Improving control of cardiovascular risk in patients with established disease

These studies show a clear focus on cardiorenal medicine and on reducing the burden of long-term vascular disease.

The site contributes to research in digestive system diseases and immune system diseases, particularly in chronic inflammatory gastrointestinal disorders. Key conditions include Crohn's disease, ulcerative colitis, and cirrhosis of the liver. These trials are generally aimed at improving disease control, measuring treatment benefit, and supporting safer long-term therapy for patients with persistent digestive and liver-related illness.

• Evaluating new options for inflammatory bowel disease
• Studying treatment effectiveness in chronic liver-related conditions
• Improving remission and symptom control in gastrointestinal inflammation

This area highlights the hospital’s role in advancing care for patients with complex gastroenterology and hepatology needs.

Research at Fakultna Nemocnica Trnava also spans respiratory tract diseases, virus diseases, and neoplasms. Trials include work in chronic obstructive pulmonary disease, severe viral lung infections, COVID-19, and several cancers such as non-small cell lung cancer, breast cancer, biliary tract cancer, prostate cancer, and head and neck squamous cell carcinoma. The research is focused on testing new treatments, improving survival, and better managing advanced disease.

• Assessing therapies for difficult-to-treat lung and viral respiratory illnesses
• Studying new approaches in advanced solid tumors
• Evaluating treatment effectiveness and safety in oncology and infectious disease settings

This broad activity shows a diverse clinical research profile with meaningful involvement in oncology and infectious disease studies.

The trial landscape also includes several studies in immune system diseases involving chronic allergic and inflammatory disorders. Main conditions include psoriatic arthritis, chronic spontaneous urticaria, chronic inducible urticaria, hidradenitis suppurativa, and bullous pemphigoid. These trials are generally designed to evaluate whether newer therapies can improve symptom control, reduce flares, and provide lasting benefit in diseases that often affect daily life.

• Testing therapies for chronic urticaria and other allergic skin conditions
• Investigating immune-targeted treatments for inflammatory joint and skin disease
• Supporting long-term safety and sustained response in chronic autoimmune disorders

This area reflects a strong emphasis on immunology and on clinical research for patients with ongoing inflammatory disease.